GlaxoSmithKline to buy Human Genome for $3bn

GSK headquarters The drugs industry has seen several takeovers and mergers recently

Related Stories

Drug company GlaxoSmithKline is to buy Human Genome Sciences for about $3bn (£1.9bn), ending a three-month pursuit of the US biotechnology firm.

The deal follows weekend talks in which the UK's largest pharmaceutical company agreed to raise its cash bid to $14.25 a share from $13.

The purchase gives GSK rights to several recently-launched medicines.

Major drugs companies are scouring the market for acquisitions as a wave of patents are about to expire.

GSK will gain control of Benlysta, which treats the immune system disorder lupus, as well as experimental medicines for diabetes and heart disease.

"Benlysta is actually going to be a good drug. Glaxo wanted to get this on the cheap and they were able to do it in the absence of other bidders," said analyst Carol Werter, from Summer Street Research.

Biotech companies are looking to acquire a new pipeline of drugs to replace older medicines that analysts say are expiring in record numbers.

Bristol-Myers Squibb recently bought diabetes specialist Amylin Pharmaceuticals by sharing the $7bn cost of the deal with AstraZeneca.

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Business stories


Features & Analysis

  • Dana Lone HillDana Lone Hill

    The Native American names that break Facebook rules

  • Painting from Rothschild collectionDark arts Watch

    The 50-year fight to recover paintings looted by the Nazis

  • Mukesh SinghNo remorse

    Delhi bus rapist says victim shouldn't have fought back

  • Signposts showing the US and UK flagsAn ocean apart

    How British misunderstanding of the US is growing

Elsewhere on the BBC

  • StudentsBull market

    Employers are snapping up students with this desirable degree


  • 3D model of Christ the Redeemer statueClick Watch

    Using drones to 3D map the famous Brazilian landmark Christ the Redeemer

Try our new site and tell us what you think. Learn more
Take me there

Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.